Plain-English translation of NCT05982769 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether exercise—either resistance training (strength-building) or endurance training (cardio)—can help patients with cirrhosis rebuild muscle mass and reduce dangerous ammonia levels in the body. Cirrhosis damages the liver's ability to process ammonia, which can cause confusion and muscle loss. The study will compare two types of exercise over 12 weeks to see which one works better.
Patients with cirrhosis often lose muscle mass and develop ammonia buildup because their liver cannot process it normally. While some studies show endurance exercise is safe, there is very little research on how resistance exercise works or which type of exercise is best for this condition.
You likely qualify if…
You likely don't qualify if…
You will start with screening and fitness testing visits to make sure exercise is safe for you. Then you will be randomly assigned to either 12 weeks of resistance exercise, 12 weeks of endurance exercise, or standard care. If assigned to exercise, you will receive equipment to use at home and complete the program over three months. The study will measure your muscle mass, fitness level, and blood markers before, during, and after the exercise period.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States